Seretide Evohaler

Company:
GlaxoSmithKline (Ireland) Ltd
Status:
Updated
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Fluticasone PropionateSalmeterol Xinafoate
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

PA1077/046/004

25/50 microgram(s)/dose

R03AK06

Pressurised inhalation, suspension

PA1077/046/005

25/125 microgram(s)/dose

R03AK06

Pressurised inhalation, suspension

PA1077/046/006

25/250 microgram(s)/dose

R03AK06

Pressurised inhalation, suspension